Buckhead Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
1,354
-130
-9% -$132K 0.47% 56
2025
Q4
$1.59M Hold
1,484
0.57% 53
2025
Q3
$1.13M Sell
1,484
-25
-2% -$18.6K 0.41% 56
2025
Q2
$1.18M Sell
1,509
-14
-0.9% -$10.9K 0.45% 59
2025
Q1
$1.26M Sell
1,523
-172
-10% -$143K 0.4% 63
2024
Q4
$1.31M Sell
1,695
-65
-4% -$53.8K 0.42% 59
2024
Q3
$1.56M Sell
1,760
-90
-5% -$80.9K 0.49% 57
2024
Q2
$1.67M Sell
1,850
-70
-4% -$56K 0.57% 58
2024
Q1
$1.49M Sell
1,920
-184
-9% -$131K 0.51% 57
2023
Q4
$1.23M Buy
2,104
+15
+0.7% +$8.76K 0.45% 58
2023
Q3
$1.12M Sell
2,089
-61
-3% -$31.4K 0.47% 58
2023
Q2
$1.01M Sell
2,150
-23
-1% -$9.65K 0.24% 79
2023
Q1
$746K Sell
2,173
-358
-14% -$121K 0.18% 84
2022
Q4
$926K Sell
2,531
-415
-14% -$147K 0.22% 80
2022
Q3
$953K Sell
2,946
-50
-2% -$15.8K 0.25% 81
2022
Q2
$971K Buy
2,996
+4
+0.1% +$1.2K 0.24% 81
2022
Q1
$857K Hold
2,992
0.19% 94
2021
Q4
$826K Hold
2,992
0.17% 93
2021
Q3
$691K Sell
2,992
-30
-1% -$7.4K 0.15% 95
2021
Q2
$694K Sell
3,022
-50
-2% -$10K 0.15% 95
2021
Q1
$574K Buy
3,072
+75
+3% +$14.7K 0.13% 96
2020
Q4
$506K Buy
2,997
+286
+11% +$42.7K 0.13% 93
2020
Q3
$401K Buy
2,711
+265
+11% +$41K 0.11% 89
2020
Q2
$402K Buy
+2,446
New +$375K 0.12% 82

Other funds holding LLY

Buckhead Capital Management's LLY Position: Q1 2026 in Review

Buckhead Capital Management reduced its Eli Lilly (LLY) stake by 8.8% in Q1 2026, selling an estimated $132K and leaving 1,354 shares worth $1.25M. The position accounts for 0.47% of the portfolio, ranked #56.

Buckhead Capital Management first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.67M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Buckhead Capital Management held 1,354 shares of Eli Lilly worth $1.25M as of Q1 2026.
  • Buckhead Capital Management sold 130 Eli Lilly shares in Q1 2026, an estimated $132K.
  • Eli Lilly made up 0.47% of Buckhead Capital Management's portfolio in Q1 2026, its #56 holding.
  • Buckhead Capital Management first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Buckhead Capital Management's Eli Lilly position peaked at $1.67M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Buckhead Capital Management's 13F filing for Q1 2026, filed 8 May 2026.